We are looking for an outstanding "Structural Biologist/Protein
Biochemist" for our group at Heptares Therapeutics Ltd.

 

Heptares is a Drug Discovery Company located in Hertfordshire UK,
working on G protein coupled receptors involved in CNS and metabolic
disease. We are using a unique structure based approach, which
originated from work at the MRC Laboratory of Molecular Biology in
Cambridge, to characterise this important family of receptors and
develop novel innovative therapeutics for these diseases. 

We are now seeking enthusiastic and motivated scientists with experience
in the expression, purification and crystallisation of proteins to
assist Heptares in obtaining unique structures of GPCRs for drug
discovery. This is an exceptional opportunity to participate in
pioneering science whilst helping to grow an Industry-leading Drug
Discovery company. 

Applicants should have a PhD and post-graduate experience in a research
environment. Candidates should be familiar with protein expression and
purification in a variety of expression systems such as E.coli,
baculovirus and mammalian cells. We also wish to recruit candidates with
experience in protein crystallisation who are interested in following
proteins through purification to structural studies. Previous experience
of working with GPCRs or other membrane proteins would be an advantage.
Experience of working in a drug discovery environment where structural
studies are used to drive medicinal chemistry would also be of benefit. 

 

Further information can be found on our website (www.heptares.com).

 

To apply for this position, please send your application to
h...@heptares.com, quoting reference number 2011/1B

 

Best wishes,

 

Joao Dias, Ph.D.

 

Senior Scientist

Heptares Therapeutics Ltd

BioPark, Broadwater Road,

Welwyn Garden City,

Herts, AL7 3AX

UK

 

This document contains company confidential and/or proprietary
information. It is intended for the exclusive attention of the
addressee(s) above and should not be copied or disclosed to any other.
If you have received this transmission in error, please make no use of
its contents and contact the sender.

 

Reply via email to